TrademarkDir
GENSCI
LIVE

Serial Number

79349335

Owner

CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD.

Attorney

Dana Stewart-Mekdara

Filing Date

Jun 24, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GENSCI Trademark

Serial Number: 79349335 • Registration: 7292334

GENSCI is a trademark filed by CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD. on June 24, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD.

No. 72 Tianhe Street, Changchun

Entity Type: 99

Trademark Details

Filing Date

June 24, 2022

Registration Date

January 30, 2024

Published for Opposition

November 14, 2023

Goods & Services

Pharmaceutical preparations for the treatment of growth hormone deficiency in adults and children, and female reproductive disorders; hormones for medical purposes; medicines for human purposes for treatment of growth hormone deficiency in adults and children, and female reproductive disorders; crude drugs for treatment of growth hormone deficiency in adults and children, and female reproductive disorders; chemical conductors for electrocardiograph electrodes

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 23, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 6, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 6, 2026 OPNR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Mar 11, 2025 CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Jan 23, 2025 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 8, 2024 CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 14, 2024 CRCV
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 17, 2024 FINO
GENERIC MADRID TRANSACTION SENT TO IB
May 1, 2024 XXSS
GENERIC MADRID TRANSACTION CREATED
May 1, 2024 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 30, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 30, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 14, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Nov 13, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 25, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 25, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 25, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 10, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 6, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 6, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 6, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 6, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 15, 2023 TROA
REFUSAL PROCESSED BY IB
Jun 26, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 6, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jun 6, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 11, 2023 RFCR
NON-FINAL ACTION WRITTEN
Apr 10, 2023 CNRT
ASSIGNED TO EXAMINER
Apr 9, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 20, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 16, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 15, 2022 REPR

Related Trademarks